| COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo KY Salim, SM Vareki, WR Danter, J Koropatnick Oncotarget 7 (27), 41363, 2016 | 149 | 2016 |
| Neural network prediction of obstructive sleep apnea from clinical criteria SD Kirby, W Danter, CFP George, T Francovic, KA Ferguson, P Eng, ... Chest 116 (2), 409-415, 1999 | 128 | 1999 |
| Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines S Maleki Vareki, KY Salim, WR Danter, J Koropatnick PLoS One 13 (1), e0191766, 2018 | 39 | 2018 |
| Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing S Esmail, W Danter Stem cells translational medicine 10 (2), 239-250, 2021 | 27 | 2021 |
| DeepNEU: cellular reprogramming comes of age–a machine learning platform with application to rare diseases research WR Danter Orphanet journal of rare diseases 14, 1-13, 2019 | 26 | 2019 |
| COTI-2, a new anticancer drug currently under clinical investigation, targets mutant p53 and negatively modulates the PI3K/AKT/mTOR pathway KY Salim, SM Vareki, WR Danter, J Koropatnick European Journal of Cancer 1 (69), S19, 2016 | 26 | 2016 |
| Inhibitor compounds and cancer treatment methods WR Danter US Patent 8,138,191, 2012 | 26 | 2012 |
| The heart rate‐PR interval relationship: a model for evaluating drug actions on SA and AV nodal function. WR Danter, SG Carruthers British Journal of Clinical Pharmacology 30 (3), 490-492, 1990 | 16 | 1990 |
| Compounds and method for treatment of cancer WR Danter, M Brown, F Lepifre US Patent 8,034,815, 2011 | 15 | 2011 |
| DeepNEU: artificially induced stem cell (aiPSC) and differentiated skeletal muscle cell (aiSkMC) simulations of infantile onset POMPE disease (IOPD) for potential biomarker … S Esmail, WR Danter Frontiers in cell and developmental biology 7, 325, 2019 | 14 | 2019 |
| NEUBOrg: Artificially Induced Pluripotent Stem Cell-Derived Brain Organoid to Model and Study Genetics of Alzheimer’s Disease Progression S Esmail, WR Danter Frontiers in aging neuroscience 13, 643889, 2021 | 12 | 2021 |
| Compounds and method for treatment of cancer WR Danter, M Brown, F Lepifre US Patent 8,367,675, 2013 | 11 | 2013 |
| Artificially induced pluripotent stem cell-derived whole-brain organoid for modelling the pathophysiology of metachromatic leukodystrophy and drug repurposing S Esmail, WR Danter Biomedicines 9 (4), 440, 2021 | 10 | 2021 |
| Lung organoid simulations for modelling and predicting the effect of mutations on SARS-CoV-2 infectivity S Esmail, WR Danter Computational and Structural Biotechnology Journal 19, 1701-1712, 2021 | 9 | 2021 |
| Inhibitor compounds and cancer treatment methods WR Danter US Patent 8,580,792, 2013 | 9 | 2013 |
| Compounds and method for treatment of cancer WR Danter, M Brown, F Lepifre US Patent 8,420,643, 2013 | 9 | 2013 |
| Compounds and method for treatment of cancer WR Danter, CKK Lau US Patent 8,466,151, 2013 | 8 | 2013 |
| Artificial neural network prediction of survival or death following admission to ICU WR Danter, T Wood, NJ Morrison Clin Invest Med 19, S14, 1996 | 8 | 1996 |
| Compounds and method for treatment of cancer WR Danter, M Brown, F Lepifre | 5 | 2015 |
| Programmable cell model for determining cancer treatments WR Danter US Patent App. 14/376,912, 2015 | 4 | 2015 |
